8952296267103/28/2026 9:39:00 AM3/28/2026 9:39:00 AMA Phase I, Open-label, Multi-center Study of KFA115 as a Single Agent and in Combination With carcinoma, MSI-H CRC, esophagogastric cancer, mesothelioma, and HNSCC, all naïve to STS_ListItem_GenericListhttps://www.uhn.ca/PrincessMargaret/Research/Cancer_Clinical_Research/Lists/PMCP Clinical Trials Data/AllItems.aspx14910https://www.uhn.caFalsehttps://www.uhn.ca/PrincessMargaret/Research/Cancer_Clinical_Research{8E065694-8D88-4568-A874-E71AA1C68B7D}~sitecollection/_catalogs/masterpage/UHN/templates/PMCP_Item_Clinical_Trials.js4242
8950071470683/28/2026 9:46:23 AM3/28/2026 9:46:23 AMA Phase 1 Open-label, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics cancer, colorectal cancer, or mesothelioma, who have relapsed or progressed STS_ListItem_GenericListhttps://www.uhn.ca/PrincessMargaret/Research/Cancer_Clinical_Research/Lists/PMCP Clinical Trials Data/AllItems.aspx6510https://www.uhn.caFalsehttps://www.uhn.ca/PrincessMargaret/Research/Cancer_Clinical_Research{B94D0A63-A5F7-4171-9594-0EADD9FDF2DF}~sitecollection/_catalogs/masterpage/UHN/templates/PMCP_Item_Clinical_Trials.js4242
8954765458843/28/2026 9:38:08 AM3/28/2026 9:38:08 AMSurgery for Mesothelioma After Radiation Therapy Using Exquisite Systemic Therapy Histologically proven mesothelioma 16 Previously untreated mesothelioma 17 STS_ListItem_GenericListhttps://www.uhn.ca/PrincessMargaret/Research/Cancer_Clinical_Research/Lists/PMCP Clinical Trials Data/AllItems.aspx13600https://www.uhn.caFalsehttps://www.uhn.ca/PrincessMargaret/Research/Cancer_Clinical_Research{A614246A-90E8-4D83-B034-A9F5A647AF1A}~sitecollection/_catalogs/masterpage/UHN/templates/PMCP_Item_Clinical_Trials.js4242
8950363295933/28/2026 9:40:45 AM3/28/2026 9:40:45 AMA Phase 1/1b Open-label, Multicenter Clinical Study of MK-0472 as Monotherapy and cancer, anal squamous cancer, and mesothelioma - Arm 3 Has histologically OR STS_ListItem_GenericListhttps://www.uhn.ca/PrincessMargaret/Research/Cancer_Clinical_Research/Lists/PMCP Clinical Trials Data/AllItems.aspx5210https://www.uhn.caFalsehttps://www.uhn.ca/PrincessMargaret/Research/Cancer_Clinical_Research{716D0E5C-8BD1-499C-9741-629FE3568C8A}~sitecollection/_catalogs/masterpage/UHN/templates/PMCP_Item_Clinical_Trials.js4242
8949544704513/28/2026 9:30:50 AM3/28/2026 9:30:50 AMA Clinical Trial of Pembrolizumab (MK-3475) Evaluating Predictive Biomarkers in Subjects Cell Lung Carcinoma - Mesothelioma - Thyroid Carcinoma - Salivary Gland STS_ListItem_GenericListhttps://www.uhn.ca/PrincessMargaret/Research/Cancer_Clinical_Research/Lists/PMCP Clinical Trials Data/AllItems.aspx17600https://www.uhn.caFalsehttps://www.uhn.ca/PrincessMargaret/Research/Cancer_Clinical_Research{77B66B7F-ECE0-44EA-8CA9-38B3299B558E}~sitecollection/_catalogs/masterpage/UHN/templates/PMCP_Item_Clinical_Trials.js4242

~sitecollection/_catalogs/masterpage/Display Templates/Search/Item_Default.js
~sitecollection/_catalogs/masterpage/Display Templates/Search/Item_Default.js
~sitecollection/_catalogs/masterpage/Display Templates/Search/Item_Default.js
~sitecollection/_catalogs/masterpage/Display Templates/Search/Item_Default.js
~sitecollection/_catalogs/masterpage/Display Templates/Search/Item_Default.js
~sitecollection/_catalogs/masterpage/Display Templates/Search/Item_Default.js
~sitecollection/_catalogs/masterpage/Display Templates/Search/Item_Default.js
~sitecollection/_catalogs/masterpage/Display Templates/Search/Item_Default.js
~sitecollection/_catalogs/masterpage/Display Templates/Search/Item_Default.js

Last reviewed:
Last modified: 11/25/2024 8:17 AM
Back to Top